Roles of ErbB-3 and ErbB-4 in the physiology and pathology of the mammary gland

Kermit L. Carraway, Coralie A. Carothers Carraway, Kermit L. Carraway

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

ErbB-3 and ErbB-4 are the most recently discovered and least characterized of the class I tyrosine kinase receptors. ErbB-3 is noteworthy for its low tyrosine kinase activity, suggesting that it may function more as an adaptor in signaling than as a kinase. Heregulin serves as a ligand for both receptors. A primary mechanism of heregulin action involves heterodimerization of its targeted receptors with other members of the class I family to promote cross-phosphorylation and cellular responses. Betacellulin also acts as a ligand for ErbB-4 to stimulate its kinase activity in both homo- and hetero-dimers. A new ligand (ASGP-2) for ErbB-2 has been discovered which operates by an intramembrane mechanism and may be able to modulate external ligand-dependent ErbB-3 or ErbB-4 heterodimeric interactions with ErbB-2. Hetero-dimerization stimulated by the ligands is a key feature of mitogenic signaling in mammary epithelial cells and tumors. Characterization of the signaling pathways for these receptors is still incomplete, but phosphatidylinositol 3-kinase and SHC have been implicated. Heregulin synthesized by the mesenchyme has been implicated in mammary development, modulated by systemic hormones. Observations on cultured mammary cells and mammary tumors have suggested linkages of ErbB-3 and ErbB-4 to proliferation and differentiation, respectively, but further work is needed to establish their definitive roles.

Original languageEnglish (US)
Pages (from-to)187-198
Number of pages12
JournalJournal of Mammary Gland Biology and Neoplasia
Volume2
Issue number2
DOIs
StatePublished - Jan 1 1997
Externally publishedYes

Fingerprint

Human Mammary Glands
Neuregulin-1
Pathology
Ligands
Breast
Mucin-4
Phosphotransferases
Phosphatidylinositol 3-Kinase
Receptor Protein-Tyrosine Kinases
Dimerization
Mesoderm
Protein-Tyrosine Kinases
Cultured Cells
Epithelial Cells
Phosphorylation
Hormones
Breast Neoplasms
Neoplasms

Keywords

  • Heterodimerization
  • Ligand
  • Mammary development
  • Mammary tumors
  • Signaling
  • Tyrosine receptor kinase

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Roles of ErbB-3 and ErbB-4 in the physiology and pathology of the mammary gland. / Carraway, Kermit L.; Carothers Carraway, Coralie A.; Carraway, Kermit L.

In: Journal of Mammary Gland Biology and Neoplasia, Vol. 2, No. 2, 01.01.1997, p. 187-198.

Research output: Contribution to journalArticle

@article{ac484a185bb24c4c84b607ff52a9698b,
title = "Roles of ErbB-3 and ErbB-4 in the physiology and pathology of the mammary gland",
abstract = "ErbB-3 and ErbB-4 are the most recently discovered and least characterized of the class I tyrosine kinase receptors. ErbB-3 is noteworthy for its low tyrosine kinase activity, suggesting that it may function more as an adaptor in signaling than as a kinase. Heregulin serves as a ligand for both receptors. A primary mechanism of heregulin action involves heterodimerization of its targeted receptors with other members of the class I family to promote cross-phosphorylation and cellular responses. Betacellulin also acts as a ligand for ErbB-4 to stimulate its kinase activity in both homo- and hetero-dimers. A new ligand (ASGP-2) for ErbB-2 has been discovered which operates by an intramembrane mechanism and may be able to modulate external ligand-dependent ErbB-3 or ErbB-4 heterodimeric interactions with ErbB-2. Hetero-dimerization stimulated by the ligands is a key feature of mitogenic signaling in mammary epithelial cells and tumors. Characterization of the signaling pathways for these receptors is still incomplete, but phosphatidylinositol 3-kinase and SHC have been implicated. Heregulin synthesized by the mesenchyme has been implicated in mammary development, modulated by systemic hormones. Observations on cultured mammary cells and mammary tumors have suggested linkages of ErbB-3 and ErbB-4 to proliferation and differentiation, respectively, but further work is needed to establish their definitive roles.",
keywords = "Heterodimerization, Ligand, Mammary development, Mammary tumors, Signaling, Tyrosine receptor kinase",
author = "Carraway, {Kermit L.} and {Carothers Carraway}, {Coralie A.} and Carraway, {Kermit L.}",
year = "1997",
month = "1",
day = "1",
doi = "10.1023/A:1026360032602",
language = "English (US)",
volume = "2",
pages = "187--198",
journal = "Journal of Mammary Gland Biology and Neoplasia",
issn = "1083-3021",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Roles of ErbB-3 and ErbB-4 in the physiology and pathology of the mammary gland

AU - Carraway, Kermit L.

AU - Carothers Carraway, Coralie A.

AU - Carraway, Kermit L.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - ErbB-3 and ErbB-4 are the most recently discovered and least characterized of the class I tyrosine kinase receptors. ErbB-3 is noteworthy for its low tyrosine kinase activity, suggesting that it may function more as an adaptor in signaling than as a kinase. Heregulin serves as a ligand for both receptors. A primary mechanism of heregulin action involves heterodimerization of its targeted receptors with other members of the class I family to promote cross-phosphorylation and cellular responses. Betacellulin also acts as a ligand for ErbB-4 to stimulate its kinase activity in both homo- and hetero-dimers. A new ligand (ASGP-2) for ErbB-2 has been discovered which operates by an intramembrane mechanism and may be able to modulate external ligand-dependent ErbB-3 or ErbB-4 heterodimeric interactions with ErbB-2. Hetero-dimerization stimulated by the ligands is a key feature of mitogenic signaling in mammary epithelial cells and tumors. Characterization of the signaling pathways for these receptors is still incomplete, but phosphatidylinositol 3-kinase and SHC have been implicated. Heregulin synthesized by the mesenchyme has been implicated in mammary development, modulated by systemic hormones. Observations on cultured mammary cells and mammary tumors have suggested linkages of ErbB-3 and ErbB-4 to proliferation and differentiation, respectively, but further work is needed to establish their definitive roles.

AB - ErbB-3 and ErbB-4 are the most recently discovered and least characterized of the class I tyrosine kinase receptors. ErbB-3 is noteworthy for its low tyrosine kinase activity, suggesting that it may function more as an adaptor in signaling than as a kinase. Heregulin serves as a ligand for both receptors. A primary mechanism of heregulin action involves heterodimerization of its targeted receptors with other members of the class I family to promote cross-phosphorylation and cellular responses. Betacellulin also acts as a ligand for ErbB-4 to stimulate its kinase activity in both homo- and hetero-dimers. A new ligand (ASGP-2) for ErbB-2 has been discovered which operates by an intramembrane mechanism and may be able to modulate external ligand-dependent ErbB-3 or ErbB-4 heterodimeric interactions with ErbB-2. Hetero-dimerization stimulated by the ligands is a key feature of mitogenic signaling in mammary epithelial cells and tumors. Characterization of the signaling pathways for these receptors is still incomplete, but phosphatidylinositol 3-kinase and SHC have been implicated. Heregulin synthesized by the mesenchyme has been implicated in mammary development, modulated by systemic hormones. Observations on cultured mammary cells and mammary tumors have suggested linkages of ErbB-3 and ErbB-4 to proliferation and differentiation, respectively, but further work is needed to establish their definitive roles.

KW - Heterodimerization

KW - Ligand

KW - Mammary development

KW - Mammary tumors

KW - Signaling

KW - Tyrosine receptor kinase

UR - http://www.scopus.com/inward/record.url?scp=0031107209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031107209&partnerID=8YFLogxK

U2 - 10.1023/A:1026360032602

DO - 10.1023/A:1026360032602

M3 - Article

C2 - 10882304

AN - SCOPUS:0031107209

VL - 2

SP - 187

EP - 198

JO - Journal of Mammary Gland Biology and Neoplasia

JF - Journal of Mammary Gland Biology and Neoplasia

SN - 1083-3021

IS - 2

ER -